PLRX vs RCON
Comparison between Pliant Therapeutics Inc (PLRX, Company) and Recon Technology Ltd - Class A (RCON, Company).
PLRX is from the Healthcare sector, while RCON is from the Energy sector.
5-Year PerformancePLRX has outperformed RCON, delivering a return of -46.8% compared to -62.5%
PLRX vs RCON - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
PLRX vs RCON - Historical Returns
Returns include dividend reinvestment.
PLRX vs RCON - Annual Returns (2009 - 2026)
Returns include dividend reinvestment.
| Year | PLRX | RCON |
|---|---|---|
| 2026 | -13.60% | -72.77% |
| 2025 | -90.81% | -26.51% |
| 2024 | -26.67% | -50.12% |
| 2023 | -4.68% | -81.47% |
| 2022 | +37.09% | -8.70% |
| 2021 | -44.94% | -12.08% |
| 2020 | +6.67% | -48.96% |
| 2019 | N/A | -36.33% |
| 2018 | N/A | -44.74% |
| 2017 | N/A | -2.26% |
| 2016 | N/A | -2.99% |
| 2015 | N/A | -29.59% |
| 2014 | N/A | -37.06% |
| 2013 | N/A | +115.41% |
| 2012 | N/A | +311.76% |
| 2011 | N/A | -93.47% |
| 2010 | N/A | -28.35% |
| 2009 | N/A | +19.93% |
PLRX vs RCON Drawdown Comparison
The maximum drawdown for PLRX was -97.34%, occurring on Jul 20, 2026. This drawdown has not yet recovered.
The maximum drawdown for RCON was -99.96%, occurring on Jun 24, 2026. This drawdown has not yet recovered.
The current PLRX drawdown is -97.32%. The current RCON drawdown is -99.95%.
| Rank | PLRX | RCON |
|---|---|---|
| #1 | -97.34% Mar 25, 2021 - Jul 20, 2026 | -99.96% Sep 23, 2009 - Jun 24, 2026 |
| #2 | -43.59% Jun 29, 2020 - Feb 24, 2021 | -32.06% Aug 5, 2009 - Sep 14, 2009 |
| #3 | -21.34% Feb 24, 2021 - Mar 25, 2021 | -1.70% Sep 16, 2009 - Sep 22, 2009 |
| #4 | -5.82% Jun 4, 2020 - Jun 15, 2020 | -1.64% Sep 14, 2009 - Sep 16, 2009 |
| #5 | -2.53% Jun 15, 2020 - Jun 17, 2020 | N/A |
| #6 | -0.04% Jun 19, 2020 - Jun 23, 2020 | N/A |
Correlation
Correlation between PLRX and RCON is 0.56 which considered as a moderate positive correlation - the stocks show some tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks